SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward W. Richmond who wrote (1098)11/2/1998 8:31:00 PM
From: Chuca Marsh  Read Replies (1) of 1501
 
Hey, guy go to CSW and spend 20 cents for thye click....I have been clicking so much lately that the cents turn to dollars ! canada-stockwatch.com As you see it is not IN THE Bi Line but a 85 cents is in the Head Line, maybe> Any others with the knowledge? :( Bispan- there is an old Worm Drug, wonder if that has an excedworm Headlineache? )
Bulletin Search Results

Click the type to read it (20c), click the symbol for quote/chart (free) ( Yeah...I got my Statement recently!)

Date
Sym
Company
Type
Headline
19981102
14:09
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
Toxicology studies for asthma
compound
19981029
09:02
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
Contract with SEC target
terminated
19981028
16:30
IZP
Inflazyme
Pharmaceuticals Ltd
Street Wire
Internet tout targeted in SEC
sweep
19981022
14:07
IZP
Inflazyme
Pharmaceuticals Ltd
Miscellaneous
Warrant price amendment
19981016
14:01
IZP
Inflazyme
Pharmaceuticals Ltd
Options Granted
19981009
13:42
IZP
Inflazyme
Pharmaceuticals Ltd
Miscellaneous
Management agreement
19980810
15:20
IZP
Inflazyme
Pharmaceuticals Ltd
In the News
Fagan says drug company
undervalued
19980710
07:16
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
No explanation for market
activity
19980707
08:31
IZP
Inflazyme
Pharmaceuticals Ltd
In the News
Fagan says biotech company a
buy near 52-week low
19980625
17:09
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
$6-million private placement
completed
19980625
13:58
IZP
Inflazyme
Pharmaceuticals Ltd
Private Placement
7,017,544 shares at 85.5 cents
19980604
13:55
IZP
Inflazyme
Pharmaceuticals Ltd
Miscellaneous
Product development
agreement
19980601
16:45
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
$6m private placement
19980528
13:53
IZP
Inflazyme
Pharmaceuticals Ltd
Options Granted
19980512
17:01
IZP
Inflazyme
Pharmaceuticals Ltd
Options Proposed
19980511
13:40
IZP
Inflazyme
Pharmaceuticals Ltd
Options Granted
19980506
16:37
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
Director appointed; director
steps down
19980428
02:12
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
Options granted to directors;
IPL 576 in preclinical
toxicology testing
19980401
12:04
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
Appointment
19980205
07:03
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
Positive pre-clinical results on
IPL 423 (Bispan)
19980115
07:58
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
No material changes
19980112
07:52
IZP
Inflazyme
Pharmaceuticals Ltd
News Release
New director
Chucaupt290210 and by the numbers:<<..

Beverly Hills 90210/Papua New Guinea IPL 576,092/ Inveresk Research, Edinburgh,
Scotland 000000000#1/ IZP not a zipo hope out by Shots and Mac Beath( an "a" for
my Scot Heritage added!) Outta a Spota @ Zip Code Revision-80 cents per share he
betta( beta factor) get the results a Shotas/ kappa factor X or it is..>>>
Hey Chuck S- reply anyway -damed if I can rember the SUBJECT...e mail always welcomed, also...bondee@ma.ultranet.com
Lurkers also! I saw Nortran, guess it was best and the worst 80 cent trade I ever did! Is George still around! Nice guy...but his wife....dam too similar to my misses, with me in Real estate, it scares me!( he knows Meds The Old Fashioned way- He learns from his wife at the Dinner Table ...or he don't EAT! ) ( A guess- a joke!)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext